HAIs

Read this informative article on mitigating central line-associated bloodstream infections (CLABSIs) in acute care settings, which is crucial for enhancing patient safety.

Enjoy this first installment of The Long-Term Care Chronicles With Robbie Hilliard, MSN, RN CIC, a column about managing special infection control situations in the long-term care patient population. This installment is about when 2 experts conflict about best care.

As infectious diseases resurge in 2024, this article explores how IPs can manage outbreaks, allocate resources, use technology for surveillance, and collaborate with senior leaders to ensure business continuity and patient safety in health care settings.

Effective implementation of UV-C disinfection is crucial to reducing HAIs. The Providence Holy Cross Medical Center achieved a 19% reduction in multidrug-resistant HAIs and saved $1.2 million through strategic deployment, highlighting the importance of collaboration and innovative management.

Maintaining team morale during financial instability and potential layoffs requires clear communication, emotional support, and professional development opportunities to reassure and retain valuable team members.

Infection Control Today® speaks with the 2023 Infection Control Today’s Educator of the Year Award™ winner, Sharon Ward-Fore, MS, MT,(ASCP), CIC, FAPIC

Transplants are a crucial yet complex part of acute care. They involve various organs and tissues, necessitating robust infection prevention programs and compliance with strict regulatory standards.

Utilizing robust quality systems is essential in medical device manufacturing to prevent infections and extend the lifespan of instruments, ensuring optimal patient safety.

Complicated and untreatable gonococcal infections due to antimicrobial-resistant gonorrhea are outpacing the advancements and development of novel antibiotics and testing technologies.

Consistent infection prevention (IP) rounding in ambulatory clinics fosters compliance, collaboration, and education, improving infection prevention through relationship-building and just-in-time learning.

Infection Control Today's Product Locator is a monthly column highlighting some of the latest advanced technology in infection prevention.

During delivery, babies can acquire infections if they come into contact with pathogens present in the birth canal or from the mother’s genital tract.

Recent medical advances include RNA vaccine technology, enhanced understanding of immune dysregulation, improved inter-specialty communication, deeper insights into inflammation, and recognition of biological complexity.

Meet the experts shaping infection prevention: Infection Control Today's Editorial Board members share insights, experiences, and cutting-edge strategies to enhance health care safety and quality. Meet Henry Spratt, Jr, PhD.

A new medical device uses microneedles and a suction cup to simplify blood sampling. It aids needle-phobic patients and benefits low-income regions with cost-effective diagnostics.

A recent study published in JAMA discusses the efficacy and safety of acetaminophen in sepsis patients.

Discover the critical connection between sepsis and nonventilator hospital-acquired pneumonia (NV-HAP), impacting healthcare quality measures and patient outcomes.

Tisha Mitsunaga, DrPH, ScM, discusses innovative approaches fostering collaboration between public health and healthcare facilities to combat multidrug-resistant organism (MDRO) spread.

A study presented at the Society for Healthcare Epidemiology of America (SHEA) conference evaluated adherence to laxative administration guidelines before CDI testing in Veteran Affairs (VA) hospitals and explored associated demographic and contextual factors.

Hospitals using CDC prevention strategies had different incidences of hospital-associated Clostridioides difficile infection compared to those that didn't, but the reasons are not necessarily the strategies themselves.

Read on about how, as hospitals grapple with the costly burden of healthcare-associated infections (HAIs), artificial intelligence (AI) emerges as a game-changer in revolutionizing infection prevention strategies.

Merck's V116, a 21-valent pneumococcal vaccine, exhibits strong immunogenicity and coverage in diverse adult populations. Real-world data reveal its potential to combat pneumococcal diseases effectively.

Carole W. Kamangu, MPH, RN, CIC, shares her inspiring journey from the Democratic Republic of Congo to health care leadership in the US today. (This is the French translation of the interview with Carole W. Kamangu.)

Carole W. Kamangu, MPH, RN, CIC, shares her inspiring journey from the Democratic Republic of Congo to health care leadership in the US today.

Recent research in the American Journal of Infection Control reveals gaps in routine hospital disinfection, highlighting the need for UV-C audits. Learn how to validate UV-C dosages effectively and conduct successful audits.